Main Session
Sep
30
QP 17 - Hem 3: Radiating Precision: Tailoring Therapy for Lymphoma, Leukemia, and Myeloma
1101 - Consensus Organ at Risk (OAR) Constraints for Radiotherapy (RT) for Hematologic Malignancies for NCTN Trials
Presenter(s)
Austin Sim, MD, JD - The Ohio State University Comprehensive Cancer Center, Columbus, OH